QA: NextCure Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001661059_2023_NextCure_Inc.pdf

Logs

Graph

Absolute values for 0001661059, NextCure Inc.

  xvar xval
0 AssetsCurrent 163,983,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 11,897,000
3 remainder_Assets 8,281,000
4 LiabilitiesCurrent 9,127,000
5 LiabilitiesNoncurrent 7,504,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 21,710,000
9 ResearchAndDevelopmentExpense 54,199,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 1,176,000
13 remainder_ComprehensiveNetIncome -831,000
  yvar yval
0 Assets 184,161,000
1 Liabilities 16,631,000
2 Expenses 75,909,000
3 Revenues 0
4 StockholdersEquity 167,530,000
5 NetIncome -74,733,000
6 ComprehensiveNetIncome -75,148,500
7 BaseVar 139,354,000
8 EconomicCapitalRatio 2.12

Edgar->Model Mapping

Feature Distribution

Change over Time